83 related articles for article (PubMed ID: 8352181)
1. Interrelation between angiographic severity of coronary artery disease and plasma levels of insulin, C-peptide and plasminogen activator inhibitor-1.
Negri M; Sheiban I; Arigliano PL; Tonni S; Montresor G; Carlini S; Manzato F
Am J Cardiol; 1993 Aug; 72(5):397-401. PubMed ID: 8352181
[TBL] [Abstract][Full Text] [Related]
2. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
4. High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.
Ihnken K; Speiser W; Ruf W; Thiel W; Schlepper M; Müller-Berghaus G
Ann Hematol; 1993 Nov; 67(5):237-44. PubMed ID: 8241347
[TBL] [Abstract][Full Text] [Related]
5. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
[TBL] [Abstract][Full Text] [Related]
7. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease.
Ossei-Gerning N; Wilson IJ; Grant PJ
Thromb Haemost; 1998 Apr; 79(4):736-40. PubMed ID: 9569183
[TBL] [Abstract][Full Text] [Related]
9. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
[TBL] [Abstract][Full Text] [Related]
10. Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease.
Seljeflot I; Eritsland J; Torjesen P; Arnesen H
Scand J Clin Lab Invest; 1994 May; 54(3):241-6. PubMed ID: 8036449
[TBL] [Abstract][Full Text] [Related]
11. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
[TBL] [Abstract][Full Text] [Related]
12. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
Hamsten A; Syvänne M; Silveira A; Luong LA; Nieminen MS; Humphries S; Frick MH; Taskinen MR
Thromb Haemost; 2000 Mar; 83(3):397-403. PubMed ID: 10744143
[TBL] [Abstract][Full Text] [Related]
13. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
Akanji AO; Al-Shayji I
Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
[TBL] [Abstract][Full Text] [Related]
14. Release of platelet plasminogen activator inhibitor 1 in whole blood is increased in patients with type II diabetes.
Jokl R; Klein RL; Lopes-Virella MF; Colwell JA
Diabetes Care; 1995 Aug; 18(8):1150-5. PubMed ID: 7587850
[TBL] [Abstract][Full Text] [Related]
15. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women.
Os I; Nordby G
J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S15-21. PubMed ID: 1283764
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of insulin resistance in coronary artery disease documented with angiography.
Shinozaki K; Suzuki M; Ikebuchi M; Hara Y; Harano Y
Diabetes Care; 1996 Jan; 19(1):1-7. PubMed ID: 8720524
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary artery disease.
Grancha S; Estellés A; Tormo G; Falco C; Gilabert J; España F; Cano A; Segui R; Aznar J
Thromb Haemost; 1999 Apr; 81(4):516-21. PubMed ID: 10235431
[TBL] [Abstract][Full Text] [Related]
18. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
